FDA Accepts Wearable Cough Sensor for Tool Program

- Sibel Health, a Northwestern University spin-out, has developed the ANNE One platform which is capable of monitoring a wide range of physiological parameters. These include heart rate, respiratory rate, skin temperature, oxygen saturation, and body position, making its application broader than just cough monitoring. The company has raised a total of $105M and is backed by investors including the Gates Foundation, National Institutes of Health, and Samsung NEXT Ventures. - The FDA's Clinical Outcome Assessment (COA) qualification is a multi-year process concluding that a tool is a well-defined and reliable measure for its specified use in clinical trials. Once qualified, a tool can be used by any company in drug development for that specific context without the FDA needing to re-evaluate its suitability, which can expedite the development and regulatory review of new drugs. On average, it takes six years for a COA to become qualified. - Digital biomarkers are objective, quantifiable physiological and behavioral data collected by digital devices like wearables or sensors. They are transforming clinical trials by enabling continuous, real-world data collection, which offers a more dynamic understanding of disease progression compared to intermittent, subjective measurements taken in a clinic. This can potentially reduce clinical trial sample sizes and shorten durations. - The global mobile health (mHealth) app market was valued at approximately $56.3 billion in 2024 and is projected to grow to $184.7 billion by 2033. This growth is driven by increased smartphone penetration and a rising prevalence of chronic diseases that benefit from continuous tracking. - Successful user acquisition for health apps often involves a multi-channel approach, including App Store Optimization (ASO), targeted social media marketing with user-generated content, and content marketing that establishes the brand as a trusted expert. Retention strategies focus on delivering consistent value and using analytics to refine features that encourage long-term user loyalty. - For direct-to-consumer health apps, HIPAA regulations generally do not apply if the app collects health information directly from consumers for their own use. HIPAA's stringent privacy and security rules become mandatory when an app is used by or on behalf of a "covered entity," such as a healthcare provider or health plan, to create, store, or transmit Protected Health Information (PHI). - The use of wearables for continuous monitoring aligns with the "quantified self" and biohacking movements, where individuals track detailed biometric data to optimize health and longevity. Technologies like smart rings and continuous glucose monitors are used to make data-driven adjustments to lifestyle, nutrition, and recovery routines.